PPARG and neurodegenerative disease: Pioglitazone, a peroxisome proliferator-activated receptor-gamma (PPARγ) agonist used clinically as an anti-diabetic medication, is known to exert various biological functions such as reducing inflammation and oxidative injury and may use for stroke or other neurodegenerative diseases [149].